Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01441791 · ClinicalTrials.gov registry record · NA

PROVHILO:Protective Ventilation During General Anesthesia for Open Abdominal Surgery

A NA study, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Completed
Registry status
NA
Development phase
900
Enrollment target

NCT01441791: Completed NA study, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

NCT01441791 is a NA study that has completed, run by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The registered enrollment target is 900 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01441791, a NA study, has completed, sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

COMPLETED
Registry status
NA
Development phase
900 participants
Enrollment target

Study Summary

The purpose of this international, multicentre, double-blinded randomized controlled trial is to determine if the "open lung approach" providing recruitment maneuvers and PEEP(Positive End Expiratory Pressure) during general anesthesia reduces atelectasis formation and improves respiratory function in the immediate post-operative period after major abdominal surgery. Participating centres throughout the world will include a total of 900 adult patients undergoing general anesthesia for open abdominal surgery with high or intermediate risk for post-operative pulmonary complications. Patients are randomized and intra-operatively ventilated with either a lung protective strategy (PEEP at 12 cmH2O with recruitment maneuvers) or a conventional strategy (PEEP at maximum 2 cmH2O without recruitment maneuvers). Patients will be assessed on the first 5 post-operative days, on day of discharge and on day 90 post-operative. Primary endpoint is any post-operative pulmonary complication (see below). Secondary endpoints are post-operative extra-pulmonary complications, intra-operative mechanical ventilation related complications, unscheduled ICU (Intensive Care Unit) (re-) admission, and length of hospital stay.

Primary Outcome

Mild respiratory failure Severe respiratory failure ALI/ARDS (Acute Lung Injury and Acute Respiratory Distress Syndrome) Suspected pulmonary infection Pulmonary infiltrate Pleural effusion Atelectasis Pneumothorax Bronchospasm Aspiration pneumonitis Cardiopulmonary edema

Interventions

  • PROCEDURE Lung protective strategy ventilation

Trial Details

FieldValue
Enrollment Target 900 participants
Start Date 2011-02
Est. Completion 2013-04
Phase NA

What the finished NCT01441791 record still lists

NCT01441791 is an interventional study that assigns participants to a tested intervention. The registered 900 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (36% lower).

The record links to 0 conditions, and to 1 intervention - of which Lung protective strategy ventilation is the first listed.

NCT01441791 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01441791 about?

NCT01441791 is a clinical study titled "PROVHILO:Protective Ventilation During General Anesthesia for Open Abdominal Surgery". The purpose of this international, multicentre, double-blinded randomized controlled trial is to determine if the "open lung approach" providing recruitment maneuvers and PEEP(Positive End Expiratory Pressure) during general anesthesia reduces atelectasis formation and improves respiratory function ...

What is the current status of trial NCT01441791?

This trial is currently completed. It is a NA study. The enrollment target is 900 participants. The study started on 2011-02. Estimated completion is 2013-04.

What interventions are being tested in trial NCT01441791?

The interventions under investigation include: Lung protective strategy ventilation (PROCEDURE).

Who is sponsoring clinical trial NCT01441791?

This trial is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01441791's enrollment target sits among peer trials

900 124th of 2000 higher than 1,871 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02352116 · 900 participants · NA

    Evaluation of Post-PACU Pain Management in Pediatric Surgery

  • NCT02414347 · 900 participants

    F 18 T807 Tau PET Imaging of Alzheimer's Disease

  • NCT02670408 · 900 participants

    Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

  • NCT02960022 · 900 participants · Phase 2

    A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01441791, the US trial registry maintained by the National Library of Medicine. NCT01441791 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.